Is TAVR right for you?
More than one million people in the United States suffer from aortic stenosis. One-third of those patients are considered to have severe aortic stenosis, requiring an aortic valve replacement. Most patients are able to undergo open-heart surgery for their valve replacement, which is considered the gold standard. However, if you are considered inoperable or high-risk because you may be too weak or sick for traditional valve replacement, you may be a candidate for transcatheter aortic valve replacement or TAVR.
Luckily, the FDA approved this new procedure that allows patients to receive a new valve without open-heart surgery. And Missouri Baptist Medical Center is one of the few centers in the area to offer this life-saving procedure.
The new TAVR procedure allows a team of cardiologists and cardiac surgeons to insert a new valve inside your diseased valve without open heart surgery. The new valve is put in place through a catheter that is inserted through the groin or between the ribs.
For more information on TAVR or to schedule an appointment at the Heart Valve Center, call MoBap at 314-996-3627
or email us
The Edwards SAPIEN valve is the first and only FDA-approved transcatheter aortic heart valve in the U.S.
What happens in the TAVR procedure?
The new aortic valve is inserted over a wire through a catheter that is threaded into place from a small incision in the leg or between the ribs with no open chest incision necessary. The diseased valve is first enlarged with a small balloon, and then the replacement valve is thread through the vascular system on a balloon to the heart where high resolution X-ray and sonography equipment is used to place the valve in the right location.
Once the valve is in the right location in the heart, the balloon is expanded and the valve is deployed. Additional pictures are taken of the heart with X-ray and sonography to assure that the valve has been appropriately placed and is functioning properly. The groin is then closed and the patient remains in the hospital for continued monitoring. When the patients’ recovery is complete, the patient is then discharged, often 2-10 days after the procedure. View a diagram outlining the steps of the procedure.
Patients who are considered inoperable or high-risk may receive the new valve through a catheter inserted into the top of the leg, or groin area. Watch an animation of the transfemoral procedure.
Patients who are considered high-risk and whose anatomy may not be acceptable for the transfemoral approach (such as very petite patients), they may receive the new valve through a catheter inserted between the ribs. Watch an animation of the transapical procedure.
Because of the minimally invasive procedure, the patient’s hospital stay may be reduced by days. Patients may leave the hospital between 2-10 days after the procedure, which may be shorter than a traditional heart surgery. Shortly after discharge, the patients are living a better life and able to do most normal tasks again.
Many TAVR patients are home within a week and soon after return to a more healthy and active lifestyle.
For more information on TAVR or to schedule an appointment at the Heart Valve Center, call MoBap at 314-996-3627 or contact us online.